ground-breaking data: phase 3 adaura trial
Published 4 years ago • 93 plays • Length 5:08Download video MP4
Download video MP3
Similar videos
-
3:16
adaura phase iii trial data: practice changing?
-
6:23
adaura trial; early stage non–small cell lung cancer
-
2:06
adaura trial: osimertinib for early stage egfr nsclc - 2022 program: targeted therapies forum
-
1:45
phase iii data support frontline osimertinib in egfr-mutant lung cancers
-
4:25
adaura: osimertinib as adjuvant therapy in stage iii egfr nsclc
-
11:20
the oncology brothers discuss adaura trial findings
-
2:20
adjuvant osimertinib in resected egfrm nsclc: the os data from the adaura trial
-
39:16
webinar: lung cancer clinical trials evaluating efficacy and overcoming resistance | veeda
-
1:17:31
immunotherapy's dynamic evolution in metastatic, locally advanced, and early-stage nsclc
-
4:47
asco 2023 expert report on novelties in oncogene driven nsclc by a. curioni-fontecedro
-
6:20
asco 2023 highlights on adjuvant osimertinib in resected egfr mutated nsclc: the adaura trial
-
0:58
adaura study demonstrates promising efficacy for osimertinib in egfr-mutant nsclc
-
5:54
key points from the adaura trial: osimertinib - targeted therapies in lung cancer 2023
-
59:19
precision oncology in early-stage lung cancer, with adjuvant egfr-targeted therapy leading the way
-
3:30
adaura: osimertinib adjuvant therapy on cns disease recurrence
-
1:08
adaura clinical trial update
-
16:41
asco lung cancer roundtable - trial updates in nsclc - adaura trial and post surgery egfr mutation
-
11:37
asco23 - lba3: os analysis from the adaura trial of adjuvant osimertinib in resected egfr‐mutate...
-
5:12
adaura trial: tagrisso & resectable egfr - leading developments & current questions in lung cancer
-
2:13
overall-survival analysis of adaura: osimertinib in resected egfrm stage ib-iiia nsclc
-
5:03
adaura results: adjuvant osimertinib for egfrm non-small cell lung cancer
-
12:24
stephen liu md talks to us about the adaura trial